I see the ODC website has been updated...
I was reading through the THC quarterly and it seems our eyes are too big for our bellies at THC which generally isn't a bad thing but it could be in MM field. Maybe someone can clarify to me but where the hell is all our patients going to come from for all that product?
Supply is controlled.
Manufacturing licences will be refused if the applicant cannot demonstrate that supply will be in accordance with all pre-requisites.
Sure seems alot of product for Clinical trials, Special Access Scheme and Authorised Prescribers (AP). State and territory governments may also have additional requirements for supply, such as patient cohorts or specific indications.
- Forums
- ASX - By Stock
- EPN
- THC Global
THC Global, page-67
Featured News
Add EPN (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable